Clearside Biomedical, Inc.
CLSD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $7 | $9 | $14 | $20 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $1 | $2 | $1 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $2 | $1 | $1 |
| Total Curr. Assets | $8 | $12 | $16 | $21 |
| Property Plant & Equip (Net) | $3 | $4 | $4 | $4 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $3 | $4 | $4 | $4 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $12 | $15 | $20 | $25 |
| Liabilities | – | – | – | – |
| Payables | $1 | $1 | $2 | $1 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $1 | $1 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $2 | $1 | $2 | $3 |
| Total Curr. Liab. | $3 | $3 | $5 | $5 |
| LT Debt | $0 | $0 | $54 | $52 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $63 | $61 | $7 | $7 |
| Total NC Liab. | $63 | $61 | $61 | $59 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $1 | $1 | $1 |
| Total Liabilities | $66 | $64 | $66 | $64 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$374 | -$368 | -$363 | -$355 |
| AOCI | $0 | $0 | $0 | -$0 |
| Other Equity | $320 | $319 | $318 | $316 |
| Total Equity | -$54 | -$49 | -$46 | -$39 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $12 | $15 | $20 | $25 |
| Net Debt | -$6 | -$9 | $40 | $32 |